Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphoblastic lymphoma in adults.

D E Slater, R Mertelsmann, B Koziner

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |January 1, 1986
    PubMed
    Summary

    Intensive chemotherapy for lymphoblastic lymphoma (LBL) shows a 45% 5-year survival rate, comparable to acute lymphoblastic leukemia (ALL). Poor prognostic factors include age, high white blood cell count, and delayed complete response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing post-stroke cognition in pre-clinical models: lessons and recommendations from a multi-center study.

    bioRxiv : the preprint server for biology·2025
    Same author

    Canadian Surgery Forum.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Intradermal testing for autoimmune progesterone dermatitis: should we be basing the diagnosis on it?

    Clinical and experimental dermatology·2021
    Same author

    Optimal Timing of CT Scanning in the Rapid Access Lung Cancer Clinic.

    Irish medical journal·2020
    Same author

    Fracture union rates across a century of war: a systematic review of the literature.

    BMJ military health·2020
    Same author

    Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.

    British journal of anaesthesia·2019

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Medicine

    Background:

    • Lymphoblastic lymphoma (LBL) is a rare non-Hodgkin lymphoma.
    • Treatment strategies have evolved significantly over time.
    • Understanding prognostic factors is crucial for patient management.

    Purpose of the Study:

    • To review the outcomes of patients with lymphoblastic lymphoma (LBL) treated with intensive chemotherapy.
    • To compare treatment response and survival rates between leukemic and nonleukemic LBL.
    • To identify prognostic factors influencing survival in LBL patients.

    Main Methods:

    • Retrospective review of 51 patients with LBL treated with intensive chemotherapy protocols.
    • Comparison of clinical and laboratory parameters between leukemic and nonleukemic groups.

    Related Experiment Videos

  • Analysis of prognostic factors and survival rates.

    • Main Results:

    • Projected 5-year survival rate of 45% for LBL patients treated with L10/17 protocols.
    • Treatment response was similar to that of 111 acute lymphoblastic leukemia (ALL) patients.
    • Poor prognostic factors identified: age >30, WBC >50,000/microL, failure to achieve complete response (CR), and late CR.

    Conclusions:

    • Intensive chemotherapy protocols represent a significant advancement in LBL treatment.
    • Leukemia at presentation, T cell markers, and mediastinal mass did not negatively impact survival.
    • Prognostic factors like age and WBC count are critical for predicting outcomes in LBL.